L

Life Science REIT PLC
LSE:LABS

Watchlist Manager
Life Science REIT PLC
LSE:LABS
Watchlist
Price: 38.8 GBX 0.52% Market Closed
Market Cap: 135.8m GBX
Section:
 

Relative Value

The Relative Value of one LABS stock under the Base Case scenario is 40.17 GBX. Compared to the current market price of 38.8 GBX, Life Science REIT PLC is Undervalued by 3%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

LABS Relative Value
Base Case
40.17 GBX
Undervaluation 3%
Relative Value
Price
L
Worst Case
Base Case
Best Case

Valuation Multiples

6.5
P/S
P/S
Price to Sales
6.5
vs History
25
vs Industry
22
Median 3Y
5.9
Median 5Y
0
Industry
3.8
Forward
6
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-9.1
Median 5Y
0
Industry
16.2
Forward
18.7
More Details
14.1
P/OCF
P/OCF
Price to OCF
14.1
vs History
15
vs Industry
28
Median 3Y
10.3
Median 5Y
0
Industry
11.2
More Details
18.8
P/FCFE
P/FCFE
Price to FCFE
18.8
vs History
9
vs Industry
50
Median 3Y
-174.7
Median 5Y
0
Industry
12.8
More Details
0.6
P/B
P/B
Price to Book Value
0.6
vs History
45
vs Industry
60
Median 3Y
0.6
Median 5Y
0.6
Industry
0.9
More Details
6.2
EV/S
EV/S
Enterprise Value to Sales
6.2
vs History
39
vs Industry
18
Median 3Y
6.3
Median 5Y
0
Industry
6.9
Forward
5.8
More Details
8.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
8.6
vs History
39
vs Industry
24
Median 3Y
8.7
Median 5Y
0
Industry
12.5
More Details
12.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
12.5
vs History
39
vs Industry
14
Median 3Y
12.6
Median 5Y
0
Industry
15.8
Forward
8.5
More Details
12.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
12.5
vs History
39
vs Industry
21
Median 3Y
12.6
Median 5Y
0
Industry
19.1
Forward
8.8
More Details
13.6
EV/OCF
EV/OCF
Enterprise Value to OCF
13.6
vs History
39
vs Industry
28
Median 3Y
13.7
Median 5Y
0
Industry
18.5
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-165.6
Median 5Y
0
Industry
20.5
More Details
0.4
EV/IC
EV/IC
Enterprise Value to IC
0.4
vs History
74
vs Industry
49
Median 3Y
0.6
Median 5Y
0.6
Industry
0.8
More Details

Multiples Across Competitors

LABS Competitors Multiples
Life Science REIT PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Life Science REIT PLC
LSE:LABS
135.8m GBP 6.5 -4.4 12.5 12.5
US
Welltower Inc
NYSE:WELL
127.7B USD 12.9 133 37.8 84.8
US
Ventas Inc
NYSE:VTR
36.6B USD 6.6 153.6 21.6 53
US
Omega Healthcare Investors Inc
NYSE:OHI
13B USD 11.3 24.9 16.6 24
US
Healthpeak Properties Inc
F:HC5
9.8B EUR 4.1 -295.5 13 40.3
US
Physicians Realty Trust
NYSE:DOC
11.6B USD 4.1 -296.7 13 40.4
US
CareTrust REIT Inc
NYSE:CTRE
8.1B USD 18.9 31 22.6 29
US
Healthcare Trust Of America Inc
F:HT01
5.3B EUR 8 66.2 20.1 51.6
US
Healthcare Realty Trust Inc
NYSE:HR
6B USD 5 -16.3 16 172
US
Sabra Health Care REIT Inc
NASDAQ:SBRA
4.8B USD 6.4 27.3 16.1 26.9
US
National Health Investors Inc
NYSE:NHI
3.7B USD 10.4 25 17.7 25.1
P/E Multiple
Earnings Growth PEG
UK
L
Life Science REIT PLC
LSE:LABS
Average P/E: 65.9
Negative Multiple: -4.4 		N/A N/A
US
Welltower Inc
NYSE:WELL
133
28%
4.8
US
Ventas Inc
NYSE:VTR
153.6
79%
1.9
US
Omega Healthcare Investors Inc
NYSE:OHI
24.9
12%
2.1
US
H
Healthpeak Properties Inc
F:HC5
Negative Multiple: -295.5
-7%
N/A
US
Physicians Realty Trust
NYSE:DOC
Negative Multiple: -296.7
-7%
N/A
US
C
CareTrust REIT Inc
NYSE:CTRE
31
44%
0.7
US
H
Healthcare Trust Of America Inc
F:HT01
66.2
N/A N/A
US
Healthcare Realty Trust Inc
NYSE:HR
Negative Multiple: -16.3 N/A N/A
US
Sabra Health Care REIT Inc
NASDAQ:SBRA
27.3
18%
1.5
US
National Health Investors Inc
NYSE:NHI
25
6%
4.2

See Also

Summary
LABS intrinsic value, competitors valuation, and company profile.
DCF Valuation
LABS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LABS stock valuation using valuation multiples.
Wall Street Estimates
LABS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LABS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 302,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.